Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: WeissLaw LLP Investigates Osiris Therapeutics, Inc.


NEW YORK, March 15, 2019 /PRNewswire/ -- WeissLaw LLP  is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Osiris Therapeutics, Inc. ("OSIR" or the "Company") (NASDAQ: OSIR) in connection with the proposed acquisition of the Company by Smith & Nephew plc ("SNN").  Under the terms of the acquisition agreement, shareholders will receive $19.00 in cash for each OSIR share they own.  

If you own OSIR shares and wish to discuss this investigation or have any questions
concerning this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Visit our website
http://www.weisslawllp.com/osiris-therapeutics-inc/

Or follow us on Twitter @MarketsAlert

WeissLaw LLP (PRNewsfoto/WeissLaw LLP)

WeissLaw is investigating whether OSIR's Board acted to maximize shareholder value prior to entering into the agreement.  Notably, according to SNN's CEO, the acquisition of OSIR will:

Moreover, OSIR reported revenue growth of 18.7% and 22.4% for the three-month, and the nine-month periods ended September 30, 2018, respectively.

Given these facts, WeissLaw is concentrating its investigation on whether OSIR's Board conducted a fair process in agreeing to the proposed acquisition, whether the proposed acquisition undervalues the Company, and whether all material information related to the proposed acquisition is fully and fairly disclosed.   

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com

 

SOURCE WeissLaw LLP


These press releases may also interest you

at 06:50
The Board of Directors of Waddell & Reed Financial, Inc. approved a quarterly dividend on its Class A common stock of $0.25 per share payable on May 1, 2019 to stockholders of record as of April 10, 2019. Waddell...

at 06:47
Walker & Dunlop, Inc. announced today that it has appointed Christine Pratt as Vice President on the company's small loans team. Based out of Walker & Dunlop's Irvine, California office, Ms. Pratt will play a significant role in the company's new...

at 06:33
Golden Gate Sotheby's International Realty announced top producing Wine Country agent Jeffrey Earl Warren has joined the prestigious San Francisco Bay Area real estate brokerage. Besides selling major Napa Valley estates to glitterati like Carmen...

at 06:30
Imagination Park Technologies Inc.  ("Imagination Park" or the "Company"), the Company bringing augmented reality experiences to consumers and sports fans globally, today announced it is now a Microsoft Partner....

at 06:17
Q4 Sales increased 17.3% to a record high $963 million, up 22.8% in constant currency terms Record Q4 sales driven by robust business growth, led by significant outperformance in Brazil, as well as increased prices, somewhat offset by softer...

at 06:13
Bitdefender, a leading global cybersecurity company protecting over 500 million systems across 150 countries, has appointed John Stynes as its Chief Financial Officer. Stynes brings significant expertise in leading...



News published on 15 march 2019 at 18:13 and distributed by: